Total Assets for Alnylam Pharmaceuticals (ALNY)
According to Alnylam Pharmaceuticals's latest reported financial statements, the company's latest reported total assets is $4.97B USD. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and net assets for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal AssetsSwitch metric
Latest period
$4.97B
YoY change
+17.1%
5Y CAGR
+7.8%
Peak year (2025)
$4.97B
Latest annual
$4.97B
Total Assets history chart for Alnylam Pharmaceuticals (ALNY) from 2002 to 2025
Total Assets history table for Alnylam Pharmaceuticals (ALNY) from 2002 to 2025
| Fiscal year | Period ended | Reported | Total Assets | YoY |
|---|---|---|---|---|
| 2025 | $4.97B | +17.1% | ||
| 2024 | $4.24B | +10.7% | ||
| 2023 | $3.83B | +8.0% | ||
| 2022 | $3.55B | -2.7% | ||
| 2021 | $3.64B | +6.9% | ||
| 2020 | $3.41B | +42.2% | ||
| 2019 | $2.40B | +52.1% | ||
| 2018 | $1.57B | -21.1% | ||
| 2017 | $1.99B | +58.0% | ||
| 2016 | $1.26B | -8.9% | ||
| 2015 | $1.39B | +28.4% | ||
| 2014 | $1.08B | +156.7% | ||
| 2013 | $420.53M | +46.3% | ||
| 2012 | $287.52M | +2.0% | ||
| 2011 | $281.92M | -28.3% | ||
| 2010 | $393.26M | -18.3% | ||
| 2009 | $481.38M | -13.2% | ||
| 2008 | $554.68M | +12.3% | ||
| 2007 | $493.79M | +105.7% | ||
| 2006 | $240.01M | +144.0% | ||
| 2005 | $98.35M | +48.8% | ||
| 2004 | $66.11M | +87.9% | ||
| 2003 | $35.18M | +118.4% | ||
| 2002 | $16.11M | — |
Total Assets values are taken from Alnylam Pharmaceuticals's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Alnylam Pharmaceuticals (ALNY) total assets totalled $4.97B – grew 17.1% year-over-year.
Through 2020–2025 (5 years), Alnylam Pharmaceuticals total assets delivered a +7.8% annualised rate; sustaining 3 straight years of year-over-year growth.
$4.97B stands as the all-time-high annual total assets, posted in 2025, against a low of $16.11M during 2002.
Within Healthcare, Alnylam Pharmaceuticals (ALNY) ranks 9th among 8 peers we track. The peer median for total assets is $135.41B.
Alnylam Pharmaceuticals Total Assets by Year
Alnylam Pharmaceuticals Total Assets 2025: $4.97B
Alnylam Pharmaceuticals total assets in 2025 was $4.97B, grew 17.1% from 2024. This figure represents the highest annual value in the available history.
Alnylam Pharmaceuticals Total Assets 2024: $4.24B
Alnylam Pharmaceuticals total assets in 2024 was $4.24B, grew 10.7% from 2023.
Alnylam Pharmaceuticals Total Assets 2023: $3.83B
Alnylam Pharmaceuticals total assets in 2023 was $3.83B, grew 8.0% from 2022.
Alnylam Pharmaceuticals Total Assets 2022: $3.55B
Alnylam Pharmaceuticals total assets in 2022 was $3.55B, edged down 2.7% below 2021.
Alnylam Pharmaceuticals Total Assets 2021: $3.64B
Alnylam Pharmaceuticals total assets in 2021 was $3.64B.
See more financial history for Alnylam Pharmaceuticals (ALNY).
Sector peers — Total Assets
Companies in the same sector as Alnylam Pharmaceuticals, ranked by their latest total assets.
| Company | Total Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $542.90B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $309.58B | Healthcare |
| Johnson & Johnson (JNJ) | $199.21B | Healthcare |
| Merck & Co., Inc. (MRK) | $136.87B | Healthcare |
| AbbVie Inc. (ABBV) | $133.96B | Healthcare |
| AstraZeneca PLC (AZN) | $114.07B | Healthcare |
| Eli Lilly and Company (LLY) | $112.48B | Healthcare |
| Amgen Inc. (AMGN) | $90.59B | Healthcare |
Frequently asked questions
What is Alnylam Pharmaceuticals's total assets?
- Latest reported total assets for Alnylam Pharmaceuticals (ALNY) is $4.97B (period ending December 31, 2025).
How has Alnylam Pharmaceuticals total assets changed year-over-year?
- Alnylam Pharmaceuticals (ALNY) total assets changed +17.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Alnylam Pharmaceuticals total assets?
- Alnylam Pharmaceuticals (ALNY) total assets compound annual growth rate is +7.8% over the most recent 5 years available.
When did Alnylam Pharmaceuticals total assets hit its highest annual value?
- Alnylam Pharmaceuticals total assets reached its highest annual value of $4.97B in 2025.
What was Alnylam Pharmaceuticals total assets in 2024?
- Alnylam Pharmaceuticals (ALNY) total assets in 2024 was $4.24B.
What was Alnylam Pharmaceuticals total assets in 2025?
- Alnylam Pharmaceuticals (ALNY) total assets in 2025 was $4.97B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ALNY Overview
Company profile, financial tools, and key metrics
ALNY Revenue Counter
Earns $117.77 every second. See per minute, hour, and day.
ALNY Earnings Counter
Earns $9.95 per second net profit. See per minute, hour, and day.
ALNY Economic Scale
Exceeds Curacao's GDP. Compare with world economies.
ALNY What If Invested
What if you had invested $1,000? See historical returns from any date.
ALNY How It Makes Money
Discover visual breakdown of $3.71B in revenue — where it comes from and where it goes.
ALNY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ALNY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ALNY Daily Price Character
Explosive · 50.6% historical win rate (green days). Streaks & record days.
ALNY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.